A federal jury in Denver has ordered DaVita, the dialysis center chain, to pay $383.5 million to the families of three patients who died after being given GranuFlo during dialysis…
The first trial over claims that Fresenius failed to warn patients of potential cardiac arrest linked to its GranuFlo and NaturaLyte dialysis products has resulted in a defense verdict.
2016 was marked by a number of huge verdicts in crucial bellwether lawsuits and large settlement agreements over product liability claims that caused consumers to suffer severe injuries, health problems…
Kentucky has filed a lawsuit against Fresenius for promoting its GranuFlo dialysate product without warning about the risk of cardiac arrest.
A $250 million settlement agreement has been put forward by Fresenius, the makers of GranuFlo and NaturaLyte dialysis products linked to cardiac arrest.
Two Fresenius dialysis bellwether cases are being prepared for the first federal trials over the recalled drugs early next year, which could set the tone for thousands of cases to…
Fresenius has recalled more than 1.8 million bottles of NaturaLyte due to the risk of bacterial contamination, which may pose serious risks for dialysis patients.
A status conference scheduled for May 15 will involve discussions on the second phase of discovery for Fresenius dialysis bellwether cases.
A dozen Fresenius GranuFlo and NaturaLyte lawsuits are being prepared for trial, with 10 of those to be readed fro bellwether trials starting early next year.
Fresenius faces more than 2,100 wrongful death lawsuits over claims that it failed to warn doctors or patients that GranuFlo and NaturaLyte dialysis products could cause cardiac arrest.
